Scythian Biosciences - LATAM Holdings' Unit Acquisition

Scythian Biosciences - LATAM Holdings raised a round of funding on July 17, 2018. Investors include Aphria.

Scythian Biosciences is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury (TBI) with its proprietary Cannabi…

Articles about Scythian Biosciences - LATAM Holdings' Unit Acquisition: